搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
Pharmaceutical Technology
58 分钟
CFTX-1554 by Eli Lilly and Co for Peripheral Neuropathic Pain: Likelihood of Approval
CFTX-1554 is under clinical development by Eli Lilly and Co and currently in Phase I for Peripheral Neuropathic Pain.
MM&M
1 小时
2024’s most memorable pharma campaigns
From public campaigns featuring Cyndi Lauper to ads with dinosaurs, MM+M compiles the best public marketing campaigns from ...
Pharmaceutical Technology
1 小时
Abemaciclib by Eli Lilly and Co for Adipocytic Sarcoma: Likelihood of Approval
Abemaciclib is under clinical development by Eli Lilly and Co and currently in Phase I for Adipocytic Sarcoma.
Ibj.com
1 小时
IBJ’s top 10 health care stories of 2024
It’s been another busy year in Indiana health care and life sciences, with headlines nearly every week announcing another ...
protothema.gr
3 小时
The new drugs coming in 2025 for obesity, alzheimer’s, cancer, and chronic pain
The small miracles that 2024 brought to our lives lay the groundwork for new revolutionary treatments that are being prepared ...
24/7 Wall St
4 小时
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
4 小时
Lupin acquires Huminsulin from Lilly to strengthen diabetes portfolio
The Huminsulin range is vital for managing both type 1 and type 2 diabetes, helping control blood sugar levels in adults and ...
10 小时
Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?
Stock market giants including Nvidia and Walmart completed stock splits in 2024. Investors like these operations because they ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈